Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cytosorbents (CTSO) Other Non-Current Liabilities (2016 - 2017)

Cytosorbents (CTSO) has disclosed Other Non-Current Liabilities for 3 consecutive years, with $1.0 million as the latest value for Q2 2017.

  • For the quarter ending Q2 2017, Other Non-Current Liabilities fell 42.13% year-over-year to $1.0 million, compared with a TTM value of $1.0 million through Jun 2017, down 42.13%, and an annual FY2016 reading of $1.8 million, up 10.72% over the prior year.
  • Other Non-Current Liabilities was $1.0 million for Q2 2017 at Cytosorbents, down from $1.7 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $2.3 million in Q3 2016 and bottomed at $1.0 million in Q2 2017.
  • Average Other Non-Current Liabilities over 3 years is $1.7 million, with a median of $1.7 million recorded in 2017.
  • The sharpest move saw Other Non-Current Liabilities grew 10.72% in 2016, then crashed 42.13% in 2017.
  • Year by year, Other Non-Current Liabilities stood at $1.6 million in 2015, then increased by 10.72% to $1.8 million in 2016, then tumbled by 42.23% to $1.0 million in 2017.
  • Business Quant data shows Other Non-Current Liabilities for CTSO at $1.0 million in Q2 2017, $1.7 million in Q1 2017, and $1.8 million in Q4 2016.